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INTRODUCTION
Blood vessel formation is a dynamic process that is tightly regulated
to ensure oxygen homeostasis in vertebrates. During
embryogenesis, this involves the de novo formation of blood
vessels by differentiation of endothelial precursors, or angioblasts,
to form the primary vascular network (vasculogenesis), and the
formation of new blood vessels that branch off from existing vessels
(angiogenesis or neovascularization) (Carmeliet, 2000). Adult
blood vessels are normally quiescent unless the balance of
angiogenic inhibitors is tipped in favor of angiogenic activators
(termed ‘angiogenic switch’) during normal physiological processes,
such as in wound healing or during the female reproductive cycle
(Carmeliet, 2000). Angiogenesis is also crucial for the pathological
progression of tumor growth and angiogenesis-related disorders,
including many retinopathies that lead to vision loss (Arjamaa and
Nikinmaa, 2006), such as age-related macular degeneration and
diabetic retinopathies.
The hypoxia-induced transcription factor (HIF) is perceived as
the master transcriptional regulator of hypoxia-inducible genes that
are involved in adaptive cellular responses to oxygen (Kaelin, 2005),
including those genes that are involved in angiogenesis (reviewed
in Pugh and Ratcliffe, 2003; Liao and Johnson, 2007; Dewhirst et
al., 2008). HIF is a heterodimer composed of a hypoxia-regulated
alpha subunit (HIF-1, HIF-2 or HIF-3), and an oxygen-
insensitive HIF-1b subunit (also known as the aryl hydrogencarbon
receptor nuclear translocator, or ARNT) (Semenza, 2001). Under
normoxic conditions, HIF- is hydroxylated on either of two prolyl
residues by the family of prolyl hydroxylases (PHD1-3), and targeted
for rapid proteasomal degradation by a multi-subunit E3 ubiquitin
ligase complex, containing the von Hippel-Lindau (VHL) protein
as the substrate recognition component. In the absence of oxygen
or functional pVHL (the VHL gene product), HIF- protein is
stabilized and translocated to the nucleus where it partners with
HIF-b to form functional HIF, triggering an increased expression
of multiple angiogenic growth factors (Pugh and Ratcliffe, 2003),
including vascular endothelial growth factor (VEGF, or VEGFA)
(Liu et al., 1995; Forsythe et al., 1996), plasminogen activator
inhibitor-1 (PAI-1) (Kietzmann et al., 1999), angiopoietin-2 (ANG-
2) (Oh et al., 1999), platelet-derived growth factor (PDGF) (Gleadle
et al., 1995), stromal-derived factor-1 (SDF-1, or CXCL12) and CXC
chemokine receptor 4 (CXCR4) (Kryczek et al., 2005).
The secreted glycoprotein VEGFA is regarded as the key
regulator of both physiological and pathophysiological angiogenesis
as it facilitates blood vessel growth and remodeling processes by
increasing vascular permeability and changing the extravascular
matrix. Additionally, VEGFA provides mitogenic and survival
stimuli for endothelial cells (reviewed in Thomas, 1996;
RESEARCH ARTICLE
Disease Models & Mechanisms 343
Disease Models & Mechanisms 3, 343-353 (2010) doi:10.1242/dmm.004036
© 2010. Published by The Company of Biologists Ltd
von Hippel-Lindau tumor suppressor mutants faithfully
model pathological hypoxia-driven angiogenesis and
vascular retinopathies in zebrafish
Ellen van Rooijen1,2, Emile E. Voest2, Ive Logister1,2, Jeroen Bussmann1, Jeroen Korving1, Fredericus J. van Eeden3,
Rachel H. Giles2 and Stefan Schulte-Merker1,*
SUMMARY
Biallelic inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene predisposes human patients to the development of highly vascularized
neoplasms in multiple organ systems. We show that zebrafish vhl mutants display a marked increase in blood vessel formation throughout the
embryo, starting at 2 days post-fertilization. The most severe neovascularization is observed in distinct areas that overlap with high vegfa mRNA
expression, including the vhl mutant brain and eye. Real-time quantitative PCR revealed increased expression of the duplicated VEGFA orthologs
vegfaa and vegfab, and of vegfb and its receptors flt1, kdr and kdr-like, indicating increased vascular endothelial growth factor (Vegf) signaling in vhl
mutants. Similar to VHL-associated retinal neoplasms, diabetic retinopathy and age-related macular degeneration, we show, by tetramethyl rhodamine-
dextran angiography, that vascular abnormalities in the vhl–/– retina lead to vascular leakage, severe macular edema and retinal detachment.
Significantly, vessels in the brain and eye express cxcr4a, a marker gene expressed by tumor and vascular cells in VHL-associated hemangioblastomas
and renal cell carcinomas. VEGF receptor (VEGFR) tyrosine kinase inhibition (through exposure to sunitinib and 676475) blocked vhl-/–-induced
angiogenesis in all affected tissues, demonstrating that Vegfaa, Vegfab and Vegfb are key effectors of the vhl–/– angiogenic phenotype through Flt1,
Kdr and Kdr-like signaling. Since we show that the vhl–/– angiogenic phenotype shares distinct characteristics with VHL-associated vascular neoplasms,
zebrafish vhl mutants provide a valuable in vivo vertebrate model to elucidate underlying mechanisms contributing to the development of these
lesions. Furthermore, vhl mutant zebrafish embryos carrying blood vessel-specific transgenes represent a unique and clinically relevant model for
tissue-specific, hypoxia-induced pathological angiogenesis and vascular retinopathies. Importantly, they will allow for a cost-effective, non-invasive
and efficient way to screen for novel pharmacological agents and combinatorial treatments.
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Yancopoulos et al., 2000; Carmeliet, 2005). Recently, it was shown
that autocrine VEGFA signaling is also required for vascular
homeostasis (Lee et al., 2007). VEGFA acts through two high affinity
receptor tyrosine kinases, FLT-1 (VEGFR1) and KDR (VEGFR2 or
Flk-1). KDR is thought to mediate most of the angiogenic functions
of VEGFA, whereas FLT1 may act as a sink for VEGFA, or as a
decoy receptor to negatively regulate signaling through KDR
(Yancopoulos et al., 2000).
Overproduction of hypoxia-inducible mRNAs, including
VEGFA, is a hallmark of the highly vascularized neoplasms
associated with biallelic inactivation of the VHL tumor suppressor
gene, including hemangioblastomas of the retina and central
nervous system (CNS), and clear cell renal cell carcinoma (ccRCC)
(Maher et al., 1991; Maher and Kaelin, 1997; Van Poppel et al., 2000;
Lonser et al., 2003). Hemangioblastomas are the most common
manifestation of VHL disease, affecting 60-80% of all patients, and
frequently causing neurological morbidity and mortality (Wanebo
et al., 2003; Chew, 2005). These cystic tumors contain many thin-
walled blood vessels that are separated by non-invasive neoplastic
VHL–/– stromal cells (Vortmeyer et al., 1997), which were shown
to be embryonically arrested hemangioblasts that express
brachyury, KDR and the stem cell leukemia factor (SCL) (Park et
al., 2007). Besides retinal hemangioblastomas, VHL patients can
develop retinal neovascularization that is similar to diabetic
retinopathy (Chew, 2005). Although activated HIF is a major
contributor to the vascularization phenotype of VHL-associated
neoplasms, pVHL appears to be essential for endothelial
extracellular fibronectin matrix deposition in a HIF-independent
fashion (Ohh et al., 1998; Bluyssen et al., 2004; Tang et al., 2006).
Furthermore, it has been shown that endothelial cells require pVHL
for correct vascular patterning and maintenance of vascular
integrity during development (Tang et al., 2006).
We recently reported that zebrafish (Danio rerio) with mutations
in the VHL ortholog vhl display general hypoxic physiology,
including the upregulation of hypoxia-induced genes, and a severe
hyperventilation and cardiophysiological response (van Rooijen et
al., 2009). Furthermore, vhl mutants have severe hematopoietic
defects, closely resembling the human VHL-associated disorder
Chuvash polycythemia.
Here, we investigate the effect of vhl loss on blood vessel
formation. The zebrafish vascular system shows a remarkable
functional conservation with humans (Vogel and Weinstein, 2000;
Isogai et al., 2001; Zon and Peterson, 2005; Covassin et al., 2006).
This has also been demonstrated in a pathological context, as tumor
cells excreting human VEGFA strongly promoted zebrafish vessel
remodeling and angiogenesis (Stoletov et al., 2007). Furthermore,
the VEGF signaling pathway is highly conserved. Like all
vertebrates, with the exception of placental mammals, zebrafish
have four Vegf receptors (Flt1, Kdr, Kdr-like and Flt4); Kdr-like (also
known as Kdrl) was lost during the evolution of placental mammals
(Bussmann et al., 2007; Bussmann et al., 2008). Although Kdr and
Kdr-like represent separate classes of Vegf receptor, the duplicated
VEGFA orthologs Vegfaa and Vegfab can bind to, and activate, both
receptors in vitro (Bahary et al., 2007).
Using blood vessel-specific transgenes, we show severe
neovascularization of the vhl–/– brain, eye and trunk. We observed
vascular leakage in the vhl–/– retina that results in severe macular
edema and retinal detachment, resembling VHL-associated
vascular neoplasms and diabetic retinopathies. Quantitative real-
time PCR (qPCR) indicates that there is increased Flt1, Kdr and
Kdr-like signaling in vhl mutants. Treatment with VEGFR tyrosine
kinase inhibitors that are used in the cancer clinic halted excess
blood vessel formation, demonstrating that Vegfaa/b and Vegfb act
as key effectors of the vhl–/– angiogenic phenotype by signaling
through the Flt1, Kdr and Kdr-like receptors. We validate zebrafish
vhl mutants as an important new in vivo model for pathological
angiogenesis and vascular retinopathies.
RESULTS
vhl mutants display increased Flt1, Kdr and Kdr-like signaling
Through HIF-, VHL plays a crucial role in the adaptive cellular
response to hypoxia, including the regulation of angiogenesis
through factors such as VEGFA. We have previously shown that
vhl loss-of-function mutants display a systemic hypoxic response,
including the upregulation of several angiogenesis-related genes
(van Rooijen et al., 2009). At around 7.5 days-post fertilization (dpf),
whole-mount in situ hybridization results revealed an
overexpression of vegfa (vegfaa) mRNA, predominantly in the vhl
mutant brain, eye and glomerulus. Increased kdr and kdr-like (also
known as kdrl) mRNA expression was observed in blood vessels,
the liver and the glomerulus. Additionally, kdr was expressed highly
in the vhl–/– eye.
Here, we investigated the contribution of other Vegf signaling
pathway components by qPCR. We identified the vertebrate VEGF
ligands and performed synteny analyses using the Ensembl database
(http://www.ensembl.org). We constructed a rooted neighbor-
joining phylogenetic tree (Fig. 1A) showing the conservation of
VEGF ligands in zebrafish. The duplicated zebrafish VEGFA
orthologs vegfaa and vegfab (Bahary et al., 2007), as well as
zebrafish vegfc (Ober et al., 2004) and vegfd (Song et al., 2007), have
all been described previously. From our analyses, we identified
zebrafish vegfb, which is syntenic to human VEGFB (not shown)
and with orthologs that are present in other fish species. The
placental growth factor (PGF) locus is duplicated in the zebrafish,
fugu and stickleback. Zebrafish pgfa is syntenic with human PGF,
and zebrafish pgfb is syntenic with pgfa (not shown), indicating
that a fish-specific duplication event occurred during evolution.
To investigate the expression levels of all Vegf ligands and
receptors, qPCR analyses were performed on embryos at 7.25 dpf
(Fig. 1B). vhl mutants displayed a significant upregulation of flt1
(2.42-fold), kdr (4.53-fold) and kdr-like (2.65-fold) receptors,
accompanied by increased vegfaa (3.04-fold), vegfab (9.16-fold) and
vegfb (2.70-fold) ligand expression. flt4, vegfc, vegfd and pgfb levels
were not altered significantly, and pgfa could not be detected. These
data suggest that Flt1-, Kdr- and Kdr-like-mediated signaling is
increased in vhl mutants.
vhl mutants display increased angiogenesis
We crossed vhl mutant alleles into a kdr-like:egfp transgenic (TG)
background and observed a marked increase in the number of
blood vessels throughout the vhl–/– embryo. Although
vasculogenesis is seemingly unaffected at the morphological level
(not shown), angiogenesis is enhanced, as first evidenced by the
increase of cranial blood vessels at around 58 hours post-
fertilization (hpf ) (Fig. 2A). The trunk vasculature is unaffected
at this stage; however, blood vessels appear dilated (Fig. 2B). At
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3.5 dpf, blood vessels can be observed throughout the forebrain
and midbrain of vhl mutants. Furthermore, compared with their
siblings, most vessels in vhl–/– zebrafish appear dilated, including
the ventral aorta (VA), branchial arches (AA), prosencephalic
artery (PrA) and mesencephalic vein (MsV) (arrowheads, Fig. 2A
IV). In the trunk, aberrant angiogenic sprouting emanates from
the intersomitic vessels (ISV), mainly in regions that are dorsal
to the horizontal myoseptum (arrowheads, Fig. 2B XI). By 5.75
dpf, strong neovascularization of the entire vhl–/– brain is
observed (Fig. 2A VI). Similarly, the trunk vasculature in vhl
mutants is expanded, forming a complex of functional vessels (Fig.
2B XII) through which blood flow was observed (not shown).
Disease Models & Mechanisms 345
































































































































































































































































































































Fig. 1. vhl mutants display increased Flt1, Kdr and Kdr-like signaling. (A)Rooted neighbor-joining phylogenetic tree of vertebrate VEGF ligands. The different
colors represent different classes of VEGF ligands. The bar indicates an evolutionary distance of 0.2 amino acid substitutions per position. (B)qPCR at 7.25 dpf
revealed that, compared with siblings, the Vegf receptors flt1, kdr and kdr-like, and the Vegf ligands vegfaa, vegfab and vegfb, are significantly upregulated in vhl
mutants. erythropoietin (epo) was used as a positive control. The threshold cycle (Ct) values were corrected for the 18S housekeeping gene. vhl mutant cDNA
concentrations were calculated in arbitrary units compared with the sibling average, and are represented as the fold change with the sibling value set to 1. A
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To investigate whether lymphangiogenesis is affected, we
examined 7.5-dpf vhl mutants expressing both the fli1:egfp (marking
both blood and lymph vessels) and kdr-like:rfp (marking only blood
vessels) transgenes. Although confocal analysis of the trunk revealed
that vhl mutants display a slightly dilated thoracic duct (TD),
lymphangiogenesis was not obviously affected (Fig. 2C). In
accordance with our qPCR data showing unaltered flt4, vegfc and
vegfd expression levels in vhl mutants, we conclude that the vhl–/–
angiogenic response is restricted to the blood vasculature at the
stages analyzed.
Neovascularization, macular edema and retinal detachment in the
vhl–/– retina
Since retinal vascular lesions are the most common and earliest
manifestations of VHL disease (Wong et al., 2007), we investigated
the vhl mutant eye vasculature. The zebrafish embryonic eye is
nourished by choroidal vessels overlying the retinal pigmented
epithelium (RPE) and by a central retinal artery, from which
hyaloid vessels branch by angiogenesis and attach to the back of
the lens (Alvarez et al., 2007). Confocal analysis of vhl mutant eyes
revealed a dramatic increase in both the choroidal (Fig. 3A I,III)
and the hyaloid (Fig. 3A II,IV) vascular networks compared with
siblings at 5.75 dpf.
VHL-associated retinal and CNS hemangioblastomas display
increased expression of the chemokine receptor CXCR4 and its
ligand SDF-1 in tumor and vascular cells (Zagzag et al., 2005).
CXCR4 is regulated by HIF and VEGFA (Zagzag et al., 2006), and
CXCR4/SDF-1 and VEGFA have been shown to synergize in the
context of angiogenesis (Kryczek et al., 2005). In zebrafish, the
CXCR4 gene is duplicated into cxcr4a and cxcr4b, with both
fulfilling distinct functions (Chong et al., 2001). In Fig. 3B, we show
that cxcr4a is expressed in blood vessels in the vhl–/– brain and
retina, whereas in siblings, no vascular expression could be
detected. cxcr4b is expressed in the pronephric hematopoietic tissue
(supplementary material Fig. S1), which is expanded in vhl mutants,
as described previously (van Rooijen et al., 2009). Interestingly,
although we see a marked increase in blood vessels throughout the
vhl mutant embryo, cxcr4a-positive blood vessels can only be
observed in the distinct areas where high vegfaa mRNA expression
is detected (supplementary material Fig. S1). This is most striking
dmm.biologists.org346
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Fig. 2. vhl mutants display increased
angiogenesis. (A)Confocal analysis of the cranial
vasculature in TG(kdr-like:egfp) embryos. From 58
hpf, an increased number of cranial blood vessels
are visible in the vhl mutant (arrowheads, panel
IV). At 3.5 (V) and 5.75 dpf (VI), blood vessels are
observed throughout the vhl–/– forebrain and
midbrain. Compared with siblings (II), most vhl–/–
vessels appear dilated, including the VA-AA, PrA
and MsV (arrowheads, V). (B)Confocal analysis of
the trunk vasculature in TG(kdr-like:egfp) embryos.
At 58 hpf, no difference in vascular patterning is
observed between vhl mutants (X) and their
siblings (VII), although the vhl–/– DA, ISVs and
DLAV appear dilated. At 3.5 dpf, aberrant
angiogenic sprouts are observed in the vhl mutant
(arrowheads, XI), which originate from the ISVs
and are mainly located dorsal to the horizontal
myoseptum. By 5.75 dpf, neovascularization of the
vhl–/– trunk vasculature is observed (XII), forming a
complex of functional vessels with blood flow (not
shown). (C)Compared with age-matched siblings,
lymphangiogenesis is unaffected in 7.5-dpf vhl
mutants carrying the fli1:egfp (marking blood and
lymph vessels) and kdr-like:rfp (marking blood
vessels) transgenes. Arrowheads point to the TD
just ventral to the DA. Anterior is to the left in all
images. EGFP, enhanced green fluorescent
protein; RFP, red fluorescent protein; PrA,
prosencephalic artery; MsV, mesencephalic vein;
DLV, dorsal longitudinal vein; VA-AA, ventral aorta-
branchial arches; DLAV, dorsal longitudinal
anastomotic vessel; ISV, intersegmental vessel; DA,
dorsal aorta; PCV, posterior cardinal vein; C, cloaca;
PAV, parachordal vessel; VTA, vertebral artery; TD,
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in the vhl–/– brain and in the vhl–/– eye, where cxcr4a-positive blood
vessels were detected in the retina and not in the neovascularized
choroidal vessels overlying the RPE (Fig. 3B).
In mammals, primary retinal vessels branch to form intraretinal
capillaries that form plexi within the inner and outer plexiform
layers; by contrast, these networks of vessels are not present in the
largely avascular zebrafish eye (Wittenberg and Wittenberg, 1974;
Alvarez et al., 2007; Fruttiger, 2007). Accordingly, intraretinal
vessels are not observed in the sibling eye at 7.5 dpf (Fig. 3B,C I-
III). Histological analysis of the vhl–/– retina, however, reveals the
presence of cxcr4a-positive blood vessels (containing blood cells),
predominantly in the inner plexiform layer (IPL) at 7.5 dpf
(arrowheads, Fig. 3B,C IV).
A common clinical feature of VHL-associated and diabetic
retinopathies is the development of macular edema, which is the
accumulation of fluid in the central part of the retina (Tranos et
Disease Models & Mechanisms 347
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Fig. 3. Neovascularization, macular edema and retinal detachments in the vhl–/– retina. (A)Confocal analysis of the eye vasculature in TG(kdr-like:egfp) vhl
mutant embryos reveals a dramatic increase in both the hyaloid (arrow, AIII, lateral view) and choroid (AIV, ventral view) vascular networks compared with
siblings at 5.75 dpf. (B)In situ hybridization reveals cxcr4a expression in blood vessels (arrowheads) in the vhl mutant brain and retina, as shown in whole-mount
(I,III) and eosin-counterstained (II,IV) sections through the eye. No vascular cxcr4a expression was detected at 7.5 dpf in siblings. (C)Histological analysis of
periodic acid-Schiff (PAS)-stained sibling (I-III) and vhl–/– (IV-VI) retinas at 7.5 dpf. Although intraretinal vessels are not observed in the sibling eye, vhl mutant
retinas revealed the presence of blood vessels (arrowheads, IV) that contain blood cells, predominantly in the IPL. Furthermore, several lesions were observed in
the different retinal layers (asterisks, IV-VI), suggestive of macular edema predominantly in the INL and PCL. Retinal detachment of the retinal nerve layers from
the RPE was also observed (arrow, VI). (D)Electron microscopy analysis of the vhl–/– retina at 7.5 dpf shows that these retinal lesions contain electron-dense
material, confirming the development of macular edema. Fluid accumulation is observed between the nuclei of the INL, and reaching into the OPL and PCL. It
even appears that nuclei from the INL are pushed out into the OPL (arrowheads) or the IPL (arrow, CIV). This was never observed in siblings. (E)Confocal analysis
of sibling and vhl mutant retinas 20-25 hours after cardiac administration of 2,000,000 MW TAMRA at 7.25 dpf. Although retinal abnormalities were never
observed in siblings (I), vhl mutants show TAMRA accumulation in the retinal lesions (II) and between the outer retinal cell layers (III). Bars, 5mm (D); 10mm (E).
NCA, nasal ciliary artery; IOC, inner optic circle; OA, optic artery; OV, optic vein; CVP, choroidal vascular plexus; RPE, retinal pigmented epithelium; OPL, outer
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al., 2004). Although a broad range of pathologies can induce
macular edema, in these particular instances, edema is caused by
fluid leakage from the neovascularized retinal capillaries
(breakage of the inner retina-blood barrier) (Tranos et al., 2004).
Owing to the hydrostatic characteristics of the distinct retinal
nerve layers (with the plexiform layers being high-resistance
barriers to flow) (Antcliff et al., 2001), macular edema is mainly
observed in the outer retinal nerve layers, including the inner
nuclear layer (INL) and the photoreceptor cell layer (PCL) (Ciulla
et al., 2003; Tranos et al., 2004). If left untreated, it can cause
detachment of the retinal layers from the RPE and lead to vision
loss.
Histological analyses revealed multiple retinal lesions in the outer
retinal layers of the vhl–/– eye (asterisks, Fig. 3C IV-VI), suggestive
of macular edema. This was most pronounced in the ventral half
of the mutant eye. In 95.8% (n23/24) of the examined vhl–/– eyes,
severe macular edema was observed predominantly in the INL and
PCL (Fig. 3C IV-VI), and mostly in close proximity to the outer
plexiform layer (OPL). In 14.3% (n4/28) of the vhl–/– eyes,
additional sites of retinal detachment of the retinal nerve layers
from the RPE were observed (Fig. 3C VI). These retinal
abnormalities were never observed in age-matched sibling eyes
(n24/24). Electron microscopy analysis confirmed these vhl–/–
retinal lesions to represent macular edema since they contained
electron-dense material that was not observed in siblings (n2/2)
at 7.5 dpf. As shown in Fig. 3D, accumulation of this material was
observed between the nuclei of the INL, and reaching into the OPL
and PCL. It even appeared that nuclei from the INL were pushed
out into the OPL (arrowheads, Fig. 3D) or IPL (white arrow, Fig.
3C IV) by the accumulating fluid.
To investigate whether the observed macular edema is caused
by vascular leakage, we performed fluorescent angiographies at
6 dpf with a high molecular weight rhodamine-dextran conjugate
(2,000,000 MW TAMRA) that is normally too large to pass
through the vessel wall. At approximately 20-25 hours post-
injection, embryos were fixed and subjected to confocal analysis.
In Fig. 3E, nuclear counterstaining revealed that while retinal
abnormalities were never observed in siblings, TAMRA clearly
accumulates in the vhl–/– retinal lesions and at distinct locations
between the outer retinal cell layers, indicating sites of macular
edema.
The vhl–/– retinal vasculature is leaky
Confocal analysis of the optic artery and the inner optic circle after
TAMRA injection in 6-dpf kdr-like:egfp transgenic embryos
revealed severe vascular leakage through the vessel wall into the
surrounding tissue (white arrows) in vhl mutants. Three-
dimensional (3D) reconstructions from confocal stacks are
presented in Fig. 4A-C (see supplementary material Movie 1 for a
3D movie animation of these images). Taken together, these data
suggest that neovascularization of the choroidal vasculature in the
vhl–/– eye induces vascular leakage, leading to severe macular edema
in the outer layers of the retina, irregularities in the retinal layers,
and eventually retinal detachment. Although vhl mutant embryos
do not develop typical hemangioblastomas, these data indicate that
the vhl–/–-associated angiogenic phenotype shares distinct
characteristics with VHL-disease manifestations, and more
generally with other vascular retinopathies.
Vegf receptor tyrosine kinase inhibition blocks vhl–/– pathological
angiogenesis
To investigate whether the VEGF signaling pathway is necessary
and sufficient to induce the observed vhl-associated
neovascularization in our mutant zebrafish, we treated embryos
with two multi-targeted VEGF receptor tyrosine kinase inhibitors:
676475 (Calbiochem) and sunitinib malate (or Sutent). Blocking
VEGF has been shown to inhibit vasculogenesis, angiogenic
formation of the ISVs, and formation of the DLAV, when
administered very early during zebrafish development (Chan et al.,
2002; Lee et al., 2002). Therefore, to ensure proper patterning of
the cranial and trunk vasculature prior to treatment, we initiated
exposure to each individual VEGFR inhibitor at 58 hpf, when the
first vascular abnormalities were observed in vhl mutants. Embryos
were incubated with 10 mM 676475, 0.2 mM sunitinib or DMSO
(vessel control) in embryo medium for 3 days (Fig. 5). Confocal
analysis of the head, eye and trunk vasculature at 5.75 dpf revealed
that the pathological angiogenesis in vhl mutants was almost
completely blocked by 676475, and completely blocked by sunitinib
treatment. Unfortunately, owing to the accumulation and auto-
fluorescence of the yellow substance from the sunitinib solution in
the skin (which also occurs in human patients), it was not possible
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Fig. 4. The vhl–/– retinal vasculature is leaky. Confocal analysis of the retinal
vasculature 20-25 hours after TAMRA injection in 7-dpf TG(kdr-like:egfp)
embryos. (A)A 3D reconstruction of the sibling optic artery revealed that
TAMRA was contained within the blood vessel. (B,C)vhl mutants display severe
vascular leakage through the vessel wall into the surrounding tissue (arrows),
as shown in the optic artery (B) and the inner optic circle (C). (A’-C’) Z-stack
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to analyze the choroidal vasculature by confocal microscopy. Our
results indicate that vhl mutants provide a new and clinically
relevant model that is suitable for large-scale compound screens
for anti-angiogenic agents and combinatorial treatments.
DISCUSSION
VHL disease is characterized by the development of highly
vascularized neoplasms that overexpress a variety of angiogenic
factors, including VEGFA, KDR and CXCR4 (Chan et al., 2005;
Zagzag et al., 2005; Liang et al., 2007; Park et al., 2007). Similarly,
we show that loss of vhl in zebrafish embryos induces severe
pathological neovascularization, with increased Vegf signaling and
cxcr4a expression in the brain and retina. Comparable to VHL-
associated retinal neoplasms, diabetic retinopathy and age-related
macular degeneration, we show by TAMRA angiographies that
vascular abnormalities in the vhl–/– retina lead to vascular leakage,
severe macular edema and retinal detachment.
Although hemangioblastomas were not found in our vhl mutant
embryos or in heterozygote adult zebrafish, the observed vhl–/–
retinal neovascularization appears to be more similar to a new class
of ocular VHL disease that was more recently identified in a large
prospective case study (Chew, 2005). Of the VHL patients with
ocular lesions, a novel ocular manifestation similar to diabetic
retinal neovascularization was identified in 17 patients (8.3%).
Although these neovascular lesions are less common than
hemangioblastomas, the actual incidence might be higher owing
to the fact that they have not been attributed to loss of pVHL.
Vascular abnormalities have been observed in murine Vhlh (also
known as Vhl) models. Conventional Vhlh knockout mice (Gnarra
et al., 1997), and mice harboring a targeted deletion of Vhlh in
endothelial cells (Tang et al., 2006), are embryonic lethal [death
occurs between embryonic day (E)9.5-12.5] owing to hemorrhagic
lesions and vascular abnormalities in the placenta. Deletion of Vhlh
in the epidermis (Boutin et al., 2008) and liver (Haase et al., 2001;
Rankin et al., 2005) resulted in increased angiogenesis in the
targeted organ systems, and mosaic Vhlh inactivation (Ma et al.,
2003) or systemic Vhlh+/– mice often develop hepatic cavernous
hemangiomas. However, hemangioblastomas of the retina and CNS
have not been found in any Vhlh mouse model. Therefore, the fact
that the vhl zebrafish survives past embryogenesis, and that
additional organ systems are affected, underscores the
complementary nature of these two models in studying hypoxia-
induced angiogenesis.
It was shown that the development of vascularized tumors in
Vhlh-deficient livers was entirely dependent on HIF (Rankin et al.,
2005). This finding supports our data, indicating that systemic
stabilization of Hif through the loss of vhl is the most likely initiator
of vegf-induced vhl–/– neovascularization. However, it has been
shown that, during mouse development, endothelial cells require
Vhlh for correct vascular patterning and maintenance of vascular
integrity (Tang et al., 2006), through HIF-independent regulation
of fibronectin deposition (Ohh et al., 1998; Tang et al., 2006).
Therefore VHL-induced changes in the extravascular matrix
probably contribute to the characteristics of the vascular neoplasms
in VHL patients, however, this needs to be investigated further.
In recent years, VEGF, its receptors and the HIF signaling
pathway have, in general, received considerable attention as
potential therapeutic targets for cancer and other angiogenesis-
related disorders. However, the current in vitro and in vivo models
for angiogenesis fail, to a certain extent, to recapitulate the
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Fig. 5. Vegf receptor tyrosine kinase
inhibition blocks vhl–/– pathological
angiogenesis. TG(kdr-like:egfp) embryos
were incubated in embryo medium
containing 0.1% DMSO (vessel control),
10mM FLT1/KDR tyrosine kinase inhibitor
676475 (Calbiochem) or 0.2mM sunitinib at
58 hpf. Confocal analysis of the head (I-VI),
eye (inserts, ventral view) and trunk (VII-XII)
vasculature at 5.75 dpf revealed that the
formation of new vessels in vhl mutants is
blocked by 676475 and – even more
dramatically – by sunitinib. CVP, choroid
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complexity of angiogenesis and its microenvironment, or to allow
in vivo functional evaluations (Taraboletti and Giavazzi, 2004).
Recently, an adult zebrafish model for hypoxia-induced retinal
angiogenesis was presented (Cao et al., 2008). Adult zebrafish that
were exposed to 10% air-saturated water developed severe retinal
neovascularization after 3-12 days of incubation. The anti-VEGF
agents sunitinib and ZM323881 effectively blocked hypoxia-
induced neovascularization, demonstrating the clinical relevancy
of this retinal angiogenesis model. However, these studies are
invasive and an adult zebrafish system is less suitable for high-
throughput and cost-effective screening of novel compounds owing
to the minimal water volume required.
In this study, we showed that vhl–/– embryos develop severe
neovascularization of the choroid and hyaloid vessels; this was
blocked by treatment with the tyrosine kinase inhibitors 676475
and sunitinib. In diabetic retinopathy, age-related macular
degeneration, and VHL-associated retinal neoplasms, the
prominent vascular abnormalities induce vascular leakage, macular
edema and retinal detachment, which can lead to a complete loss
of vision (Arjamaa and Nikinmaa, 2006). Similarly, we also observed
severe macular edema and retinal detachment in vhl mutants,
which was not described in the adult zebrafish retinal angiogenesis
model (Cao et al., 2008).
Additionally, we observed an early and fully penetrant increased
angiogenic response throughout the vhl–/– embryo. Wild-type
zebrafish embryos that were kept under hypoxic conditions (partial
pressure of oxygen of 8.7 kPa) from 1 to 15 dpf did not show
significant changes in vascularization, or in the basic pattern of the
vascular bed of the trunk and gut, as compared with normoxic
animals, and the perfusion rate was increased in the trunk
musculature, unchanged in the brain and reduced in the gut
(Schwerte et al., 2003). Since, at lower oxygen levels, zebrafish
embryos do not develop properly (Schwerte et al., 2003) and adult
zebrafish die (Cao et al., 2008), the induced hypoxia in these studies
might not have been low enough to induce a similar angiogenic
response as in vhl–/– embryos.
Therefore, our data indicate that vhl mutant zebrafish embryos
represent a unique and clinically relevant angiogenesis model
where, in the context of systemic hypoxia signaling, the process of
pathological angiogenesis and vascular retinopathies can be studied
non-invasively in a tissue-specific context under normoxic
conditions. Using a blood vessel-specific transgenic background,
vhl mutant embryos allow for a cost-effective and efficient way to
screen pharmacological agents for anti-angiogenic properties and
combinatorial treatments in a whole organism setting.
METHODS
Zebrafish lines
Zebrafish were maintained as described previosuly (Westerfield,
1995). Animal experiments were conducted in accordance with the
Dutch guidelines for the care and use of laboratory animals, with
the approval of the Animal Experimentation Committee (DEC) of
the Royal Netherlands Academy of Arts and Sciences (KNAW).
The mutant alleles vhlhu2117(Q23X) and vhlhu2081(C31X) (van
Rooijen et al., 2009) were out-crossed to the transgenic lines
TG(kdr-like:egfp)s843 (Jin et al., 2005), TG(fli1a:egfp)y1 (Lawson and
Weinstein, 2002) and TG(kdr-like:ras-cherry)s916 (Chi et al., 2008;
Hogan et al., 2009). Unless indicated otherwise, transheterozygote
embryos (vhlhu2117/vhlhu2081) were used in experimental assays.
Where indicated, embryos were anesthetized with MS222 (final
concentration of 0.17 mg/ml).
Phylogenetic analysis
Phylogenetic analysis of the zebrafish Vegf ligands was performed
with the MEGA3 software package (Kumar et al., 2004), using the
PDGF and VEGF family domain (cd00135) from NCBI’s Conserved
Domain Database (CDD). Amino acid sequences were aligned with
ClustalW and a phylogenetic tree was constructed using a neighbor-
joining algorithm. The resulting tree was tested using 1000
bootstrap resamplings. Pairwise distances were calculated with the
PAM substitution matrix. Identification of vertebrate VEGF ligands
and synteny analysis was performed using the Ensembl database
(http://www.ensembl.org), release 44, April 2007. Sequences are
available upon request.
Quantitative real-time PCR
For total RNA isolation, a maximum of 40 vhl mutants and siblings
per clutch were homogenized by shredding in 600 ml of RTL lysis
buffer (Qiagen RNeasy kit) containing 10% beta-mercaptoethanol.
One volume of 70% ethanol was added and the homogenate was
loaded onto a column for total RNA isolation according to the
manufacturer’s protocol, followed by DNaseI (Promega) treatment.
The RNA quality and concentration were determined using a
NanoDrop, and verified by gel electrophoresis. cDNA was
synthesized from total RNA (1-5 mg) with random hexamers
(Biolegio, www.biolegio.nl) using reverse transcriptase M-MLV
(Promega). Primer sets were designed using Primer3
(http://frodo.wi.mit.edu/) and Limstill (http://limstill.niob.knaw.nl/)
software, with an optimal product size of 150-200 base pairs that,
where possible, spanned two exons to avoid genomic
contamination. The PCR efficiency and optimal melting
temperatures were determined per primer set, and the specificity
was verified by gel electrophoresis using standard real-time PCR
on zebrafish cDNA. See supplementary material Table S1 for primer
sequences and melting temperatures. qPCR was preformed using
the MyIQ single color real-time PCR detection system and software
(Bio-Rad). Each reaction contained: 12.5 ml SYBR Green fluorescent
label (Bio-Rad), 3 ml of 1.5 mM primer mix, 4.5 ml MQ and 5 ml
cDNA (10ng/ml). Cycling conditions were: 95°C for 3 minutes; 40
cycles of 95°C for 10 seconds and the optimal primer temperature
for 45 seconds; followed by 95°C for 1 minute; and finally 65°C for
1 minute. All reactions were performed in triplicate on cDNA
isolated from at least two different clutches of pooled vhl mutants
and siblings. Ct values were corrected for the 18S housekeeping
gene (Cooper et al., 2006). vhl mutant cDNA concentrations were
calculated in arbitrary units compared with the sibling average, and
are represented as the fold change with the sibling value set to 1.
A paired Student’s t-test was used to determine significant
differences in expression between vhl mutants and siblings.
Confocal analysis of blood vessels
Anesthetized embryos were embedded in 0.5% agarose on a coverslip,
and confocal images were collected on a Leica DM IRE2 microscope
(Leica Microsystems) using 10, 20, 40 and 63 objectives. 3D
reconstructions of confocal stacks were generated using the Volocity
software package (Improvision, www.improvision.com).
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Transversal plastic sections (7 mm) were stained with periodic acid-
Schiff (PAS) or eosin using standard protocols.
Fluorescent dye injections
Anesthetized embryos were embedded in 0.5% agarose and were
administered with 10 mg/ml of 2,000,000 MW tetramethyl
rhodamine (TAMRA; Molecular Probes) by cardiac injection at 6
dpf. Only embryos exhibiting TAMRA throughout the
cardiovascular system immediately after injection were analyzed
further. At approximately 20-25 hours post-injection, embryos were
fixed with 4% PFA for 2 hours at room temperature or overnight
at 4°C. Retinal vascular leakage was determined by confocal
analyses on sections cut on either a Microm HM650V
(http://www.microm-online.com) vibratome (75-100 mm) or a
Leica CM3050 cryostat (50 mm).
In situ hybridization
Whole-mount in situ hybridization was performed as described
(Schulte-Merker, 2002) with minor modifications. Antisense
digoxygenin (Roche)-labeled mRNA probes for cxcr4a (Chong et
al., 2001), cxcr4b (Chong et al., 2001) and vegfaa (Liang et al., 2001)
were generated as described, and purified using NucleoSpin RNA
clean-up columns (Machery-Nagel, www.macherey-nagel.com).
To improve probe penetration, 7.5-day-old larvae were partially cut
open at the level of the yolk sac extension after proteinase K
permeabilization. After in situ hybridization, pigmented embryos
were bleached in a solution containing 0.5 SSC, 5% formamide
and 10% H2O2 for 20-40 minutes. Embryos were mounted in 2%
methylcellulose on a depression slide and imaged on a Zeiss
axioplan microscope with a 5 objective.
Transmission electron microscopy
Embryos were fixed in Karnovsky fixative (2% paraformaldehyde,
2.5% glutaraldehyde, 0.08 M Na cacodylate, pH 7.4, 0.25 mM
calcium chloride, 0.5 mM magnesium chloride, set to pH 7.4) for
at least 24 hours at 4°C. Samples were postfixed in 1% osmium
tetroxide and embedded in Epon 812. Ultra-thin sections (60 nm)
were contrasted with 3% uranyl magnesium acetate and lead
citrate, and viewed with a Jeol JEM 1010 transmission electron
microscope.
VEGF receptor tyrosine kinase inhibitor treatments
2.5-day-old embryos were treated with 10 mM of the VEGF
receptor  tyrosine kinase inhibitor 676475 (Calbiochem,
http://www.merckbiosciences.co.uk/; single dose) or 0.2 mM of
sunitinib malate (Selleck Chemicals, www.selleckchem.com; daily
refreshment) in embryo medium (Westerfield, 1995), at 28°C, in
6-well culture plates containing 30 embryos per well. Control
embryos were incubated with an equivalent amount of DMSO
solution under the same conditions. Experiments were performed
in triplicate.
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